Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (512)	8/15/2002 8:43:44 AM
From: Jibacoa	Read Replies (1) of 544

CTIC Is due to continue the up-move.<g> After announcing the start of Phase II for XYOTAX on breast cancer and its Phase III on Ovarian CA, it has now been "up-graded"<g> by USB to Strong Buy with a target of $12.<g> The Seattle Co. reportedly has $6.72 in cash/share, the insiders hold 37% and had been buying lately.306 Institutions that hold 136% of the float,<g>had also been buying and there is a 22% short position (about 8x the daily average )to make things more interesting.<g> siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next